Navigation Links
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
Date:7/6/2008

eliminates the need for multiple screening and confirmatory assays, speeds up reporting and helps avoid unnecessary antibiotic use."

"CDI poses a significant challenge for healthcare facilities around the world," said Jamie Condie, Vice President and General Manager, BD Diagnostics - GeneOhm. "The introduction of the BD GeneOhm Cdiff assay demonstrates BD's ongoing commitment to develop a broad range of products that can help prevent healthcare-associated infections (HAIs). BD provides molecular tests for key pathogens associated with HAIs, including methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible Staphylococcus aureus, vancomycin-resistant Enterococci, and now Clostridium difficile."

In the United Kingdom, Clostridium difficile infections have risen 40 percent in the last three years, infecting eight times as many patients as MRSA and killing twice as many. In the United States annually, an estimated 500,000 people are hospitalized and more than 28,000 die from CDI. The average length of stay for a CDI patient is nearly three times longer than the average patient and excess healthcare costs exceed $1 billion. U.S. rates of CDI continue to increase, driven by a hypervirulent strain known as BI/NAP1/027. This dangerous strain has now been isolated in at least 38 states, Canada and 14 European countries.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in a
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014 We are ... Center ("OACM") and the Ellicott City Ambulatory Surgery Center ... Ellicott City Maryland . ... Merritt Healthcare and 14 leading Orthopaedics, Sports Medicine, Hand, ... will also accommodate the specialties of general surgery and ...
(Date:7/14/2014)... de 2014 /PRNewswire-HISPANIC PR WIRE/ -- BioAdaptives, Inc. (OTCBB:BDPT) ... , presidente de la junta directiva, ha asumido las ... señor Epling es el dueño de Ferris Holding ... su formulación, sus propiedades intelectuales y otras tecnologías a ... "El señor Gerald Epling , que ha ...
(Date:7/14/2014)... July 14, 2014 Decision Resources Group ... positively influence perceptions of emerging drugs for both ... 100 oncologists (50 medical oncologists and 50 hematological ... of managed care organizations (MCOs), reveals that despite ... the majority of payers say this designation will ...
Breaking Medicine Technology:BioAdaptives se prepara para el próximo paso 2BioAdaptives se prepara para el próximo paso 3Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 3
... 2011  VIVUS, Inc. (NASDAQ: VVUS ) today ... in The American Journal of Clinical Nutrition, ... study evaluated the long-term efficacy and safety of Qnexa ... In addition to 10% sustained weight loss, the study ...
... Reportlinker.com announces that a new market research ... Global Coronary Stents Industry ... the worldwide markets for Coronary Stents in US$ ... Segments: Bare Metal Stents, and Drug Eluting Stents. ...
Cached Medicine Technology:SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 2SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 3SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 4SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 5SEQUEL Trial Results for Qnexa® Published in AJCN Show 10% Sustained Weight Loss Over 2 Years 6Global Coronary Stents Industry 2Global Coronary Stents Industry 3Global Coronary Stents Industry 4Global Coronary Stents Industry 5Global Coronary Stents Industry 6Global Coronary Stents Industry 7Global Coronary Stents Industry 8Global Coronary Stents Industry 9Global Coronary Stents Industry 10Global Coronary Stents Industry 11Global Coronary Stents Industry 12Global Coronary Stents Industry 13Global Coronary Stents Industry 14Global Coronary Stents Industry 15Global Coronary Stents Industry 16Global Coronary Stents Industry 17Global Coronary Stents Industry 18Global Coronary Stents Industry 19Global Coronary Stents Industry 20Global Coronary Stents Industry 21Global Coronary Stents Industry 22Global Coronary Stents Industry 23Global Coronary Stents Industry 24Global Coronary Stents Industry 25
(Date:7/14/2014)... According to a recent study ... a connection between women with high levels of a ... doctors have theorized about the role stress plays in ... provide scientific support. , “Stress, if very significant, can ... Barmat, an OB/GYN who specializes in reproductive endocrinology and ...
(Date:7/14/2014)... Last month Bromell Agency officially launched the new ... more detailed information on how clients can protect and ... boats in the state of Louisiana. , The agency ... website in order to better educate clients on the ... the website, which is to display comprehensive insurance information ...
(Date:7/14/2014)... 14, 2014 There’s an old adage that ... The Lash Palette say the products offered in their ... , “You can reserve The Lash Palette for $40,” said ... Store . , Paris explained that the first 1,000 have ... 21. , She went on to point out that her ...
(Date:7/14/2014)... 2014 Seven promising startup companies ... problems have been accepted into the University ... (DHA). , The awardees were selected from ... process. They include Biomeme, Fitly, Life Patch, Curbside ... France) and Pulse InfoFrame (from Canada) —both of ...
(Date:7/14/2014)... 2014 Jordan Valley Medical Center is ... comprehensive cancer center set to open by the fall ... only hospital west of I-15 in the Salt Lake ... Additionally, Jordan Valley Medical Center has partnered with Elekta, ... planning systems for radiation therapy, radiosurgery and brachytherapy, to ...
Breaking Medicine News(10 mins):Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:The Lash Palette Preorder Event Has Officially Begun 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4Health News:Jordan Valley Medical Center Set to Break Ground with New $10 Million Cancer Center 2
... day to day life. Keeping fit costs hardly anything if ... a gym or health club,// you'll be familiar with high ... These items typically cost thousands of dollars and might be ... But you can get the same results practically for free, ...
... lasers help remove lines and wrinkled from age and ... can take its toll in later years in terms ... But, says Dr Arielle Kauvar, a dermatologist at New ... smoother, firmer appearance. ,These lasers score over ...
... of botulinum toxin eases hand spasticity among stroke survivors. Spasticity ... and it causes much disability,// because it interferes with activities ... botulinum toxin - a substance that relieves muscle tightness - ... large trial of botulinum toxin (also known as botox) in ...
... may be combined with tumor growth in mice. At ... or similar pain medications will lead to increased cancer ... further studies for managing cancer pain. ,Researchers ... of morphine, similar to doses given to cancer patients ...
... potency can be influenced by various reasons. Many advertisments ... impotence to the attention of thousands of people.// Impotence ... men are taking help, particularly as large segments of ... range from 12 million to 30 million men in ...
... An acid found naturally in the body can block the ... There is no cure for Huntington's disease (HD), which is ... But researchers at the University of Texas may be one ... with HD. ,The mice were treated with a ...
Cached Medicine News:Health News:Many factors influence sexual potency 2
... and value!, Comfortable feel and ... contoured handle , Finer control while ... action , Completely autoclavable for easy ... for recalibration , Easy-to-read precision micrometer ...
... 3730 DNA Analyzer, upgradeable to 96 capillaries, ... analysis. , Higher optical sensitivity and ... data at a lower cost. , Multiple ... Optimized polymers increase your productivity without compromising ...
... this unique offer, you can ... application. Pipetman P2 and P10 ... reagents, and P100 is perfect ... Filter Tips, which are especially ...
... an immunochromatography based one step in ... determination of Methamphetamine in human urine ... ng/mL. This assay has not been ... and is for use by Healthcare ...
Medicine Products: